Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
White adipose tissue (WAT) inflammation is a chronic, low-grade inflammatory state within WAT, characterized by adipocyte hypertrophy, cell death, immune cell infiltration, and secretion of pro-inflammatory mediators. This process is central to the pathogenesis of obesity-related metabolic diseases like insulin resistance and type 2 diabetes, contributing to systemic inflammation and ectopic lipid deposition. Therapeutic strategies aim to reduce this inflammatory state for improved metabolic health.
Varies depending on the target. Examples include: blocking cytokine signaling pathways, reducing macrophage infiltration, improving adipocyte function, modulating immune cell polarization.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on White Adipose Tissue Inflammation (WATI).